Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.
作者信息
Venkataramanan R, Jain A, Warty V W, Abu-Elmagd K, Furakawa H, Imventarza O, Fung J, Todo S, Starzl T E
机构信息
School of Pharmacy, University of Pittsburgh, Pennsylvania 15261.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 2):931-3.
Abstract
摘要
相似文献
1
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.口服给药后FK 506的药代动力学：FK 506与环孢素的比较。
Transplant Proc. 1991 Feb;23(1 Pt 2):931-3.
2
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.肝功能不全和T管夹闭对FK 506药代动力学及谷浓度的影响。
Transplant Proc. 1990 Feb;22(1):57-9.
3
Pharmacokinetics of FK-506, a novel immunosuppressant, after intravenous and oral administrations to rats.
J Pharmacobiodyn. 1991 Jan;14(1):34-42. doi: 10.1248/bpb1978.14.34.
4
Pharmacokinetics of FK 506: preclinical and clinical studies.FK506的药代动力学：临床前和临床研究。
Transplant Proc. 1990 Feb;22(1):52-6.
5
Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.
Drug Metab Dispos. 1994 Mar-Apr;22(2):194-9.
6
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.在肾移植中，基于FK 506的方案与霉酚酸酯联合给药后FK 506和霉酚酸的药代动力学。
Transplant Proc. 1998 Jun;30(4):1299-302. doi: 10.1016/s0041-1345(98)00250-4.
7
Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.与环孢素相比，FK 506对大鼠肝脏再生的增强作用。
Lancet. 1989 Nov 25;2(8674):1248-9. doi: 10.1016/s0140-6736(89)91853-9.
8
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.肝移植受者中因环孢素相关并发症而从环孢素转换为FK506治疗。
Transplant Proc. 1990 Feb;22(1):6-12.
9
Comparison of cyclosporine A and G pharmacokinetics.
Drug Metab Dispos. 1988 Nov-Dec;16(6):895-7.
10
Influence of biliary T tube clamping on cyclosporine pharmacokinetics in liver transplant recipients.
Transplant Proc. 1988 Apr;20(2 Suppl 2):512-5.
引用本文的文献
1
Safety and Efficacy of Infusional Perioperative Tacrolimus Therapy in Crohn's Disease Patients Undergoing Intestinal Resection.围手术期输注他克莫司治疗对接受肠道切除术的克罗恩病患者的安全性和有效性
Inflamm Intest Dis. 2024 Nov 18;10(1):18-33. doi: 10.1159/000542443. eCollection 2025 Jan-Dec.
2
Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.优化西班牙裔肾移植患者的他克莫司给药方案：来自真实世界数据的见解。
Front Pharmacol. 2024 Sep 19;15:1443988. doi: 10.3389/fphar.2024.1443988. eCollection 2024.
3
Tacrolimus-why pharmacokinetics matter in the clinic.他克莫司——为何药代动力学在临床中至关重要。
Front Transplant. 2023 Aug 21;2:1160752. doi: 10.3389/frtra.2023.1160752. eCollection 2023.
4
Effect of Jejunal Administration on Tacrolimus Trough Concentrations in a Pediatric Liver Transplant Recipient.空肠给药对小儿肝移植受者他克莫司谷浓度的影响。
J Pediatr Pharmacol Ther. 2022;27(4):390-395. doi: 10.5863/1551-6776-27.4.390. Epub 2022 May 9.
5
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial.在初发肝移植中经鼻胃管给药时缓释他克莫司的药代动力学特征：DIAMOND试验的一项子研究
Ann Transplant. 2019 May 14;24:268-272. doi: 10.12659/AOT.909693.
6
Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations.改良释放和速释他克莫司制剂的临床评价。
AAPS J. 2017 Sep;19(5):1332-1347. doi: 10.1208/s12248-017-0119-z. Epub 2017 Jul 17.
7
Management and clinical outcome of penetrating keratoplasty for long-term corneal changes in sympathetic ophthalmia.交感性眼炎长期角膜改变的穿透性角膜移植术的管理与临床结果
J Ophthalmol. 2011;2011:439025. doi: 10.1155/2011/439025. Epub 2011 May 5.
8
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.他克莫司在实体器官移植中的临床药代动力学与药效学
Clin Pharmacokinet. 2004;43(10):623-53. doi: 10.2165/00003088-200443100-00001.
9
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.在慢性肝移植排斥反应中，胆管上皮细胞的复制性衰老先于胆管丢失：p21（WAF1/Cip1）表达增加作为疾病标志物以及免疫抑制药物的影响。
Am J Pathol. 2001 Apr;158(4):1379-90. doi: 10.1016/S0002-9440(10)64089-8.
10
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.他克莫司（FK506）与制药/学术/监管的重重考验。
Am J Kidney Dis. 1998 Jun;31(6 Suppl 1):S7-14. doi: 10.1053/ajkd.1998.v31.pm9631858.
本文引用的文献
1
Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.环孢素在几种动物物种和人类中的处置。I. 其代谢产物的结构解析。
Drug Metab Dispos. 1984 Jan-Feb;12(1):120-6.
2
Clinical pharmacokinetics of cyclosporin.环孢素的临床药代动力学
Clin Pharmacokinet. 1986 Mar-Apr;11(2):107-32. doi: 10.2165/00003088-198611020-00002.
3
Human orthotopic liver transplantation: surgical aspects in 393 consecutive grafts.人类原位肝移植：393例连续移植的手术要点
Transplant Proc. 1988 Feb;20(1 Suppl 1):603-6.
4
Effect of bile on cyclosporin absorption in liver transplant patients.胆汁对肝移植患者中环孢素吸收的影响。
Br J Clin Pharmacol. 1988 May;25(5):579-84. doi: 10.1111/j.1365-2125.1988.tb03348.x.
5
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.FK-506对体外淋巴细胞同种异体激活的免疫抑制作用：与环孢素A的协同作用。
Transplant Proc. 1987 Oct;19(5 Suppl 6):40-4.
6
A highly sensitive method to assay FK-506 levels in plasma.一种检测血浆中FK-506水平的高灵敏度方法。
Transplant Proc. 1987 Oct;19(5 Suppl 6):23-9.
7
The oral dosage form of FK-506.FK-506的口服剂型。
Transplant Proc. 1987 Oct;19(5 Suppl 6):17-22.
8
Distribution of FK 506 in plasma lipoproteins in transplant patients.移植患者血浆脂蛋白中FK 506的分布
Transplant Proc. 1991 Feb;23(1 Pt 2):954-5.
9
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.肝功能不全和T管夹闭对FK 506药代动力学及谷浓度的影响。
Transplant Proc. 1990 Feb;22(1):57-9.
10
Pharmacokinetics of FK 506: preclinical and clinical studies.FK506的药代动力学：临床前和临床研究。
Transplant Proc. 1990 Feb;22(1):52-6.
Zotero 插件